Therefore, the ligand-receptor pair of PF4_CXCR3 from the interaction between CD14+ monocytes and HLA_DR+ Tregs may contribute to the activation of HLA_DR+ Tregs in COVID-19 patients. The gene discussed is CXCR3; the disease is COVID-19.